GH1 and hypothyroidism: The adverse events related to long-acting growth hormone treatment were numerous, e.g., injection site pruritus, arthralgia, hematoma, hematuria, adrenal insufficiency, erythema, anemia, abnormal liver function test results, peripheral edema, hypothyroidism, pyrexia, rash, headache, and vomiting.